WHO recommends that pre-exposure prophylaxis (PrEP) be offered as an additional prevention choice for HIV-negative individuals at substantial risk of HIV infection as part of combination prevention approaches.
HIV drug resistance has been rarely reported among PrEP users who tested HIV positive i...n randomized controlled trials or open-label studies. However, PrEP-selected HIV drug resistance could potentially negatively impact the effectiveness of treatment options among PrEP users who acquire HIV, since there is a potential for overlapping resistance profiles between antiretroviral drugs used for both PrEP and first-line antiretroviral therapy.
more
Technical Brief
HIV patient monitoring and case surveillance
WHO/HIV/2017.11
WHO working group on HIV incidence assays meeting report
10–11 December 2015
Glion, Switzerland
UNAIDS/WHO working group on global HIV/AIDS and STI surveillance
WHO/HIV/2017.03
Technical Brief
HIV patient monitoring and case surveillance
WHO/HIV/2017.12
Original Research
African Journal of Primary Health Care & Family Medicine
ISSN: (Online) 2071-2936, (Print) 2071-2928
Open Access
Training for Health Care Providers
Facilitators’ Manual
PQDx 0027-012-00 WHO
PQDx Public Report
May/2017, version 4.0
PQDx 0006-005-00 WHO
PQDx PR
February/2016, version 2.0
PQDx 0018-010-00 WHO
PQDx PR
July/2016, version 3.0
DHS Working Papers No. 119
DHS Working Papers No. 85
Tinkhomba teHIV/AIDS letivetwa ngulolucwaningo lweTemphilo lwa 2006-07
DHS Working Papers No. 110 | Zimbabwe Working Papers No. 11
DHS Working Papers No. 111 | Zimbabwe Working Papers No. 12
This toolkit provides a variety of resources that will help you coordinate, design, develop, deliver, and evaluate training for HIV/AIDS healthcare providers.